Head-to-head · WeighScore
Rebody Health vs Strut Health
The verdict
Strut Health takes it — 82/100 to 67.7/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Rebody Health | Strut Health |
|---|---|---|
| WeighScore | 67.7/100 | 82/100 |
| Grade | C | B− |
| Scorecard rank | #159 | #21 |
| Semaglutide | $200/mo (starting dose, compounded) | From $99/mo sublingual, $149/mo injectable |
| Tirzepatide | $250/mo (starting dose, compounded) | From $199/mo either route |
| Coverage | 47 states | 49 states (not Arkansas) |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #159 · C
Strengths
- Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
- Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
- Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
- Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
- Names its operating company (Compound Technologies Inc.) and references LegitScript approval
Where it loses points
- Individual compounding pharmacies are not named on the marketing site
- Not available in Massachusetts, Rhode Island, or Vermont
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
- Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases
Graded #21 · B−
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
Where it loses points
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring programme
- Compounded only, with no brand-name lane
- Not available in Arkansas
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.